COVID-19 Vaccination in Children 5-11 Years of Age: Practical Guidance for Discussing Risks and Benefits
In 2021, Health Canada approved the use of the Pfizer-BioNTech COVID-19 vaccine in children 5-11 years of age. As this population continues to get vaccinated, clinicians need to be prepared to effectively discuss the benefits and risks of vaccination against COVID-19 with parents who have children within this age group.
This video reviews the COVID-19 disease burden in children 5-11 years of age and discusses how to address misinformation and concerns that parents may have about COVID-19 vaccination.
Don't miss the videos that are part of the same series:
- Encouraging COVID-19 Vaccination in Adolescents 12 Years of Age and Older
- COVID-19 Vaccination: Booster Doses, Practical Guidance for Clinical Practice
This program has received an unrestricted educational grant or in-kind support from Pfizer.
Christine Palmay, MD, CCFP, FCFP
Cora Constantinescu, BSc, MD, FRCPC
After viewing this expert brief, participants will better understand:
- Discuss the importance of COVID-19 vaccination in children aged 5-11
- Address common myths and concerns regarding COVID-19 vaccination.
- Identify patients who should be offered a booster dose of an authorized COVID-19 vaccine per NACI recommendations.
- Initiate a conversation regarding COVID-19 vaccination and booster vaccination with eligible patients and/or their parents.